VCP
PJP icon

Verus Capital Partners’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Verus Capital Partners’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$19K Hold
337
– – 0.01% 822
2019
Q4 		$22K Buy
+337
New +$20.5K 0.01% 875

Other funds holding PJP

BCI
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
PAM
Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Verus Capital Partners's PJP Position: Q1 2020 in Review

Verus Capital Partners held its Invesco Pharmaceuticals ETF (PJP) position steady in Q1 2020 at 337 shares worth $19K. The position accounts for 0.01% of the portfolio, ranked #822.

Verus Capital Partners first reported a position in PJP in Q4 2019 and has held it in 2 quarters since. The position peaked at $22K in Q4 2019. 86 funds tracked by Wall St. Rank hold PJP as of Q1 2020.

  • Verus Capital Partners held 337 shares of Invesco Pharmaceuticals ETF worth $19K as of Q1 2020.
  • Verus Capital Partners left its Invesco Pharmaceuticals ETF share count unchanged in Q1 2020.
  • Invesco Pharmaceuticals ETF made up 0.01% of Verus Capital Partners's portfolio in Q1 2020, its #822 holding.
  • Verus Capital Partners first reported a position in Invesco Pharmaceuticals ETF in Q4 2019 and has held it in 2 quarters since.
  • Verus Capital Partners's Invesco Pharmaceuticals ETF position peaked at $22K in Q4 2019.
  • 86 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q1 2020.

Based on Verus Capital Partners's 13F filing for Q1 2020, filed 26 May 2020.